Prescription With Medication ErrorsNCT07002606
The General Objective of This Study is to Monitor, Assess, and Prevent the Potential Medication Errors Among Inpatients in the Tertiary Healthcare Facility of Nepal. This Study Aims to Develop and Implement the Medication Errors Reporting System in Hospital Settings.
An observational study of Prescription With Medication Errors, run by Kathmandu University School of Medical Sciences.
Trial summary
The goal of this observational study is to develop and implement Medication errors reporting system using the error reporting guidelines. The main question it aims to answer is: "Does development and implementation of Medication errors reporting guideline will help to reduce the errors rate and improve the patient… Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Prescription With Medication Errors
- What is being tested?
- medication errors reporting guidelines
- How many people
- 62 participants
- Where
- No sites listed yet
- Study dates
- 1 Jul 2025to 1 Apr 2027
- How long will I take part?
- 1 Day
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Healthcare professionals including Doctors, Nurses and Pharmacist who are working in Dhulikhel Hospital.
Who may be able to join
- For the quantitative part, the inclusion criteria are patients of all age groups and prescriptions issued to inpatients.
- For the qualitative part of the study, inclusion criteria are healthcare professionals aged more than 18 years working in Dhulikhel Hospital.
Who cannot join
- The exclusion criteria will be incomplete and unclear prescriptions.
- The healthcare persons who accepted the consent but couldn't complete the survey will be excluded from the study.
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
Rudip Thapa Assistant Professor, M.Sc. (Medical) Pharmacology contact
About this study
Official title: Monitoring, Assessment, and Prevention of Potential Medication Errors in the Tertiary Healthcare Facility of Nepal: A Mixed-method Study
The goal of this observational study is to develop and implement Medication errors reporting system using the error reporting guidelines. The main question it aims to answer is:
"Does development and implementation of Medication errors reporting guideline will help to reduce the errors rate and improve the patient safety?"
- Conditions
- Prescription With Medication Errors
- Being tested
- medication errors reporting guidelines
- Keywords
- Medication errors, Mixed method study, tertiary healthcare facility
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
medication errors reporting guidelinesOther
the intervention is designed to reduce the medication errors and develop the culture of reporting the Medication errors in clinical settings.
What is being measured
The primary outcome is the main question the study is designed to answer.
reduction in Mediation error rate
The newly developed Medication errors reporting guidelines will be implemented and will be used to evaluate the reduction in medication errors incident rates.
Measured: 6 months after the implementation of the Medication errors reporting guidelines
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Jun 2025
- Study start1 Jul 2025 (estimated)
- Primary completion1 Apr 2026 (estimated)
- Study completion1 Apr 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Prescription With Medication ErrorsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 62 participants (estimated)
- Target duration
- 1 Day
Sponsor and investigators
- Lead sponsor
- Kathmandu University School of Medical Sciences
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Rudip Thapa, Kathmandu University School of Medical Sciences
- Investigators
- Dr. Sony Shakya Professor in Pharmacology, PhD, Study director, Kathmandu University School of Medical Science
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07002606
- Sponsor's protocol ID
- 147/24
- Other IDs
- PhD- 80/8 t-HS-04
- Status last verified
- May 2025
- First submitted
- 25 May 2025
- Last updated
- 3 Jun 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Jun 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Monitoring, Assessment, and Prevention of Potential Medication Errors in the Tertiary Healthcare Facility of Nepal: A Mixed-method Study
- ClinicalTrials.gov ID
- NCT07002606
- Acronym / sponsor ID
- 147/24
- Conditions
- Prescription With Medication Errors
- Keywords
- Medication errors, Mixed method study, tertiary healthcare facility
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 62 participants (estimated)
- Lead sponsor
- Kathmandu University School of Medical SciencesUniversity, hospital or other
- Study start
- 1 Jul 2025 (estimated)
- Primary completion
- 1 Apr 2026 (estimated)
- Study completion
- 1 Apr 2027 (estimated)
- First posted
- 3 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this observational study is to develop and implement Medication errors reporting system using the error reporting guidelines. The main question it aims to answer is:
"Does development and implementation of Medication errors reporting guideline will help to reduce the errors rate and improve the patient safety?"
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Target follow-up
- 1 Day
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Healthcare professionals including Doctors, Nurses and Pharmacist who are working in Dhulikhel Hospital.
Key inclusion criteria (2 listed)
- For the quantitative part, the inclusion criteria are patients of all age groups and prescriptions issued to inpatients.
- For the qualitative part of the study, inclusion criteria are healthcare professionals aged more than 18 years working in Dhulikhel Hospital.
Key exclusion criteria (2 listed)
- The exclusion criteria will be incomplete and unclear prescriptions.
- The healthcare persons who accepted the consent but couldn't complete the survey will be excluded from the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| medication errors reporting guidelinesthe intervention is designed to reduce the medication errors and develop the culture of reporting the Medication errors in clinical settings. | Other | – |
Primary outcome
reduction in Mediation error rate
Time frame: 6 months after the implementation of the Medication errors reporting guidelines
The newly developed Medication errors reporting guidelines will be implemented and will be used to evaluate the reduction in medication errors incident rates.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Jun 2025.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Rudip Thapa Assistant Professor, M.Sc. (Medical) Pharmacology contact
Dr. Sony Shakya Professor in Pharmacology, PhD study director
Kathmandu University School of Medical Science
Questions about this trial
What is this clinical trial studying?
An observational study of Prescription With Medication Errors, run by Kathmandu University School of Medical Sciences.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 3 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Rudip Thapa Assistant Professor, M.Sc. (Medical) Pharmacology (+9779851218678, thaparudip@student.kusms.edu.np), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
reduction in Mediation error rate (time frame: 6 months after the implementation of the Medication errors reporting guidelines). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2025.